Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) NEW YORK, December 6, 2023—Julie & Holleman LLP, a nationally recognized shareholder rights law firm, is investigating the proposed $45 per share sale of Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) to AbbVie Inc. The firm… Read More »Cerevel Therapeutics Holdings, Inc.
Consolidated Communications Holdings, Inc. (Nasdaq: CNSL) NEW YORK—Julie & Holleman LLP, a nationally recognized shareholder rights law firm, is investigating the proposed $4.70 per share acquisition of Consolidated Communications Holdings, Inc. (Nasdaq: CNSL) by the company’s largest shareholder, private equity… Read More »Consolidated Communications Holdings, Inc.
Standard BioTools Inc. (Nasdaq: LAB) NEW YORK, October 4, 2023—Shareholder rights law firm Julie & Holleman LLP is investigating potential breaches of fiduciary duty relating to the proposed merger between Standard BioTools Inc. (Nasdaq: LAB) and SomaLogic, Inc. (Nasdaq: SLGC). Please… Read More »Standard BioTools Inc.
Endeavor Group Holdings, Inc. (NYSE: EDR) NEW YORK, April 26, 2023—Shareholder rights law firm Julie & Holleman LLP is investigating the proposed merger between Endeavor Group Holdings, Inc. (NYSE: EDR) and World Wrestling Entertainment, Inc. (NYSE: WWE), whereby the two entertainment… Read More »Endeavor Group Holdings, Inc.